|By PR Newswire||
|March 10, 2014 05:30 PM EDT||
NEWARK, Calif., March 10, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that it will release fourth quarter fiscal year 2013 financial results after the market closes on Wednesday, March 12, 2014. The Company will host a conference call beginning at 4:30 pm Eastern time, 1:30 pm Pacific time to discuss its results.
Participants can access the call by dialing 877-317-6789 (United States) or 412-317-6789 (international). The conference call will also be available via a live webcast on the investor relations section of Depomed's website at http://www.depomed.com. Access the website 15 minutes prior to the start of the call to download and install any necessary audio software. An archived webcast replay will be available on the Company's website for three months.
Depomed, Inc. is a specialty pharmaceutical company that commercializes products for pain and neurology related disorders. Gralise® (gabapentin) is a once-daily treatment approved for the management of postherpetic neuralgia. Zipsor® (diclofenac potassium) Liquid Filled Capsules is a non-steroidal anti-inflammatory drug indicated for relief of mild to moderate acute pain in adults. Lazanda® (fentanyl) Nasal Spray is an intranasal fentanyl drug used to manage breakthrough pain in adults (18 years of age or older) who are already routinely taking other opioid pain medicines around-the-clock for cancer pain. Gralise and other products and product candidates are formulated with Depomed's proven, proprietary Acuform® drug delivery technology. Additional information about Depomed may be found at www.depomed.com.
August J. Moretti
SOURCE Depomed, Inc.
Dec. 8, 2016 07:15 PM EST Reads: 319
Dec. 8, 2016 06:45 PM EST Reads: 925
Dec. 8, 2016 05:45 PM EST Reads: 1,714
Dec. 8, 2016 05:45 PM EST Reads: 929
Dec. 8, 2016 05:00 PM EST Reads: 1,810
Dec. 8, 2016 04:45 PM EST Reads: 1,839
Dec. 8, 2016 04:45 PM EST Reads: 2,243
Dec. 8, 2016 04:30 PM EST Reads: 1,963
Dec. 8, 2016 04:30 PM EST Reads: 357
Dec. 8, 2016 04:15 PM EST Reads: 2,309
Dec. 8, 2016 04:15 PM EST Reads: 280
Dec. 8, 2016 04:00 PM EST Reads: 1,074
Dec. 8, 2016 03:45 PM EST Reads: 1,083
Dec. 8, 2016 03:30 PM EST Reads: 1,226
Dec. 8, 2016 03:15 PM EST Reads: 313